Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcadia Biosciences (RKDA) Cash & Current Investments (2016 - 2025)

Historic Cash & Current Investments for Arcadia Biosciences (RKDA) over the last 12 years, with Q3 2025 value amounting to $5.9 million.

  • Arcadia Biosciences' Cash & Current Investments fell 1050.79% to $5.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.9 million, marking a year-over-year decrease of 1050.79%. This contributed to the annual value of $4.2 million for FY2024, which is 6356.3% down from last year.
  • As of Q3 2025, Arcadia Biosciences' Cash & Current Investments stood at $5.9 million, which was down 1050.79% from $4.5 million recorded in Q2 2025.
  • Arcadia Biosciences' 5-year Cash & Current Investments high stood at $51.9 million for Q1 2021, and its period low was $3.2 million during Q1 2025.
  • Over the past 5 years, Arcadia Biosciences' median Cash & Current Investments value was $18.5 million (recorded in 2023), while the average stood at $18.9 million.
  • Per our database at Business Quant, Arcadia Biosciences' Cash & Current Investments skyrocketed by 24826.0% in 2021 and then plummeted by 6356.3% in 2024.
  • Over the past 5 years, Arcadia Biosciences' Cash & Current Investments (Quarter) stood at $28.7 million in 2021, then decreased by 28.03% to $20.6 million in 2022, then tumbled by 43.61% to $11.6 million in 2023, then crashed by 63.56% to $4.2 million in 2024, then skyrocketed by 38.73% to $5.9 million in 2025.
  • Its Cash & Current Investments stands at $5.9 million for Q3 2025, versus $4.5 million for Q2 2025 and $3.2 million for Q1 2025.